FDA NDC Directory · JSON-LD · Markdown

Bortezomib

NDC 63759-3032 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerShilpa Medicare Limited
Marketing categoryNew Drug Application (innovator) · App NDA212782
Dosage form / routeINJECTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsBORTEZOMIB (3.5 mg/1.4mL)
Marketing started20240925
Package count1

External sources

Source: openFDA. Public-domain (CC0).